15MG
Peptide Source
Description
TIRZEPATIDE 15MG is a high-purity peptide (≥99%, HPLC-verified) supplied as lyophilized powder, intended strictly for laboratory research. Investigated in preclinical studies for adiposity, insulin resistance, and energy balance regulation. Research evaluates fat loss, metabolic markers, and tolerability in animal models. Key effects investigated in research: accelerates body fat loss; reduces appetite and food cravings; improves insulin sensitivity; increases prolonged satiety.
Mechanism of Action
This peptide acts as a selective agonist of GLP-1, GIP, and/or Glucagon receptors, modulating central and peripheral metabolic pathways. Activation of these receptors reduces appetite via hypothalamic signaling, delays gastric emptying, and increases lipid oxidation in adipose tissue, resulting in significant reduction of visceral fat and body weight in research models.
